PVLAPalvella Therapeutics, Inc.
$173.86+118% 1Y
$173.86
$75.0652 weeks$175.86
The business
How PVLA's business earns
- Share count, year on year
- +31%
Share count, year on year · more shares than a year ago
Operating margin by fiscal year
| Year | Operating margin |
|---|---|
| FY2020 | −116% |
| FY2021 | −165% |
| FY2022 | −168% |
| FY2023 | −28% |
Details›
- Net income, trailing twelve months
- −$75M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Biotechnology
The closest names by size in the same industry